首页> 外文OA文献 >Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy
【2h】

Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy

机译:高强度聚焦超声介导超声介导的数值模拟腹膜内尿溶型癌症化疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although intraperitoneal chemotherapy (IPC) has been suggested as a promising method for the management of peritoneal dissemination (PD) of ovarian or colorectal cancers, the actual clinical use of this method has been restricted due to such problems as poor drug penetration into the tumor and high side effects. It is, therefore, necessary to develop new strategies to improve the efficacy of this approach. In the present work, a new strategy is proposed based on intraperitoneal (IP) injection of thermosensitive liposomal doxorubicin (TSL-Dox) with triggered release by mild hyperthermia induced by high intensity focused ultrasound (HIFU). A computational model is developed to evaluate the proposed drug delivery system. Results show an order of magnitude increase in drug penetration depth into the tumor compared to the conventional IP delivery. Furthermore, the effects of thermal conditions applied to the tumor, TSL size, tumor vessel permeability, and tumor size are investigated. Results indicate an improved efficiency of the drug delivery by expanding the heated region, yet, it increases the risk of unintentional TSL drug load release in the peritoneal cavity. Results also indicate that smaller TSLs have better treatment outcome. However, there is a significant reduction in treatment efficacy for TSLs with sizes smaller than the vessel wall pore size. Thus, tuning the size of TSL should be based on the tumor microvascular permeability. The simulation results suggest that the TSL-Dox delivery system in smaller tumors is far advantageous than larger ones. Results of our model can be used as guidelines for future preclinical studies.
机译:虽然腹膜内化疗(IPC)被提出为卵巢或结肠直肠癌腹膜传播(Pd)的有希望的方法,但这种方法的实际临床用途受到限制,因为这种问题是患者渗入肿瘤的差高副作用。因此,有必要制定新的策略来提高这种方法的功效。在本作工作中,基于腹膜内(IP)注射热敏性脂质体DOXORUBICIN(TSL-DOX)的新策略,通过高强度聚焦超声(HIFU)诱导的轻度热疗触发释放。开发了一种计算模型来评估所提出的药物输送系统。结果显示与常规IP递送相比,药物渗透深度进入肿瘤的数量级增加。此外,研究了应用于肿瘤,TSL尺寸,肿瘤血管渗透性和肿瘤大小的热条件的影响。结果表明通过膨胀加热区域来表明药物递送的提高效率,然而,它增加了腹膜腔中无意的TSL药物负荷释放的风险。结果还表明较小的TSL具有更好的治疗结果。然而,对于小于血管壁孔径的尺寸小,对TSL的治疗效果显着降低。因此,调节TSL的大小应基于肿瘤微血管渗透性。仿真结果表明,较小肿瘤中的TSL-DOX递送系统与较大的TSL-DOX递送系统很有利于较大的肿瘤。我们的模型的结果可用作未来临床前研究的指导原则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号